Atria Investments’s BeOne Medicines Ltd ONC Stock Holding History

Atria Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Buy	1,183 +123	+12%	+$36.2K	﹤0.01%	1773
2026 Q1	$315K	Sell	1,060 -6	-0.6%	-$1.94K	﹤0.01%	1726
2025 Q4	$324K	Sell	1,066 -349	-25%	-$114K	﹤0.01%	1702
2025 Q3	$482K	Sell	1,415 -41	-3%	-$12.4K	0.01%	1432
2025 Q2	$352K	Sell	1,456 -51	-3%	-$12.5K	﹤0.01%	1615
2025 Q1	$410K	Sell	1,507 -387	-20%	-$90.5K	0.01%	1459
2024 Q4	$350K	Sell	1,894 -33	-2%	-$6.74K	﹤0.01%	1509
2024 Q3	$433K	Sell	1,927 -647	-25%	-$116K	0.01%	1401
2024 Q2	$367K	Buy	+2,574	New	+$397K	﹤0.01%	1469
2021 Q1	–	Sell	-12,733	Closed	-$3.29M	–	755
2020 Q4	$3.29M	Buy	+12,733	New	+$3.51M	0.08%	274

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atria Investments's ONC Position: Q2 2026 in Review

Atria Investments increased its BeOne Medicines Ltd (ONC) stake by 12% in Q2 2026, buying an estimated $36.2K and bringing the position to 1,183 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Atria Investments first reported a position in ONC in Q4 2020 and has held it in 10 quarters since. The position peaked at $3.29M in Q4 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Atria Investments held 1,183 shares of BeOne Medicines Ltd worth $337K as of Q2 2026.
Atria Investments bought 123 BeOne Medicines Ltd shares in Q2 2026, an estimated $36.2K.
BeOne Medicines Ltd made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1773 holding.
Atria Investments first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 10 quarters since.
Atria Investments's BeOne Medicines Ltd position peaked at $3.29M in Q4 2020.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.